STAT3 and neoplasm: Factors in the TME, including pH, oxygen supply, immune surveillance, fibroblasts and ECM, can respond to drugs and initiate signalings to activate resistance-associated pathways in tumor cells, such as the AKT, mTOR, NF-κB, and STAT3 pathways.